Saturday, July 11, 2026

pharma · Stroke · Pancreatic Cancer

Shandong Topscience Biotech

Shandong Suncadia Medicine is a pharma organization headquartered in CN. Primary therapeutic focus areas include Stroke, Pancreatic Cancer, Breast Cancer. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), an

Rizhao, CN HQ
2005 Founded
15 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Rizhao, CN
Founded
2005
Employees
15
Programs
3
Drugs
4
Patents
0

Quick answer

Shandong Suncadia Medicine is a pharma organization headquartered in CN. Primary therapeutic focus areas include Stroke, Pancreatic Cancer, Breast Cancer. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 1 (1), phase 2 (1), phase 3 (1).

Company snapshot

our products including Sodium Hyaluronate, Chondroitin Sulfate and so on have been welcomed by customers both home and abroad. And we have been the trusted supplier of raw materials for many well-known cosmetic and pharmaceutical companies worldwide.

  • 3 active pipeline program(s) linked via ClinicalTrials.gov.
  • 3 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Shandong Topscience Biotech. Not investment advice.

Lead pipeline drugs

Active clinical programs

Momentum signals

Momentum

Proprietary activity score for Shandong Topscience Biotech.

1 active signal

20 /100 +0 vs 30 days ago

Signal breakdown

  • Clinical trials 3 30d
  • Nova articles 0 30d
  • Patents filed 0 30d
  • FDA actions 0 30d
  • SEC filings 0 30d
  • Conference presentations 0 90d
  • Pipeline advances 0 30d
Competitive landscape

Competitor landscape

Therapeutic-area overlap peers from registry and pipeline signals.

Recent activity

Recent activity

Latest pipeline, patent, and corporate events for Shandong Topscience Biotech.

  1. Clinical update

    Bilateral Cerebellar deep brain stimulation — Phase 1

  2. Clinical update

    Methylthioninium — Phase 3

  3. Clinical update

    HRS-7058 — Phase 2

View all clinical trial activity →

Quick answers

Common questions about this sponsor — for analysts and search.

  • What is Shandong Topscience Biotech?

    Shandong Suncadia Medicine is a pharma organization headquartered in CN. Primary therapeutic focus areas include Stroke, Pancreatic Cancer, Breast Cancer. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, Cl

  • Is Shandong Topscience Biotech publicly traded?

    Shandong Topscience Biotech appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

  • What drugs does Shandong Topscience Biotech develop or market?

    We link 4 drug profile(s) where Shandong Topscience Biotech is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/shandong-suncadia-medicine-co#company-drugs.

  • What are the latest developments for Shandong Topscience Biotech?

    In the last 12 months our linked public records show 3 trial program update(s) and 0 US patent grant(s) tied to this profile.

  • What therapeutic areas does Shandong Topscience Biotech focus on?

    Shandong Topscience Biotech focuses on Stroke, Pancreatic Cancer, Breast Cancer based on our analysis of their pipeline programs and drug development activities.

Therapeutic focus

Therapeutic area distribution

Pipeline concentration by therapeutic area from linked clinical programs.

Programs by therapeutic area

Oncology
4
Others
3